Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care

Misconceptions and ill-founded theories can arise in all areas of science. However, the apparent accessibility of many epidemiology findings and popular interest in the subject can lead to additional misunderstandings. The article below is the third in an occasional series of short editorials highli...

Descripción completa

Detalles Bibliográficos
Autor principal: Peto, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068511/
https://www.ncbi.nlm.nih.gov/pubmed/21448174
http://dx.doi.org/10.1038/bjc.2011.79
_version_ 1782201259579670528
author Peto, R
author_facet Peto, R
author_sort Peto, R
collection PubMed
description Misconceptions and ill-founded theories can arise in all areas of science. However, the apparent accessibility of many epidemiology findings and popular interest in the subject can lead to additional misunderstandings. The article below is the third in an occasional series of short editorials highlighting some current misinterpretations of epidemiological findings. Invited authors will be given wide scope in judging the prevalence of the misconception under discussion. We hope that this series will prove instructive to cancer researchers in other disciplines as well as to students of epidemiology. Adrian L Harris and Leo Kinlen
format Text
id pubmed-3068511
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-30685112012-03-29 Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care Peto, R Br J Cancer Editorial Misconceptions and ill-founded theories can arise in all areas of science. However, the apparent accessibility of many epidemiology findings and popular interest in the subject can lead to additional misunderstandings. The article below is the third in an occasional series of short editorials highlighting some current misinterpretations of epidemiological findings. Invited authors will be given wide scope in judging the prevalence of the misconception under discussion. We hope that this series will prove instructive to cancer researchers in other disciplines as well as to students of epidemiology. Adrian L Harris and Leo Kinlen Nature Publishing Group 2011-03-29 2011-03-29 /pmc/articles/PMC3068511/ /pubmed/21448174 http://dx.doi.org/10.1038/bjc.2011.79 Text en Copyright © 2011 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Editorial
Peto, R
Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care
title Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care
title_full Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care
title_fullStr Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care
title_full_unstemmed Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care
title_short Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care
title_sort current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068511/
https://www.ncbi.nlm.nih.gov/pubmed/21448174
http://dx.doi.org/10.1038/bjc.2011.79
work_keys_str_mv AT petor currentmisconception3thatsubgroupspecifictrialmortalityresultsoftenprovideagoodbasisforindividualisingpatientcare

Ejemplares similares